Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss | 14 | 2025 | 95 | 4.420 |
Why?
|
| Telemedicine | 10 | 2025 | 490 | 3.100 |
Why?
|
| Deafness | 6 | 2023 | 35 | 3.040 |
Why?
|
| Hearing Loss, Noise-Induced | 4 | 2023 | 10 | 2.020 |
Why?
|
| Otitis Media | 2 | 2025 | 36 | 1.870 |
Why?
|
| School Health Services | 3 | 2025 | 53 | 1.850 |
Why?
|
| Alaska | 11 | 2025 | 27 | 1.820 |
Why?
|
| Hearing Tests | 4 | 2025 | 28 | 1.470 |
Why?
|
| Rural Population | 6 | 2025 | 587 | 1.450 |
Why?
|
| Rural Health Services | 3 | 2025 | 177 | 1.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2025 | 9 | 0.960 |
Why?
|
| Hearing Loss, High-Frequency | 1 | 2023 | 5 | 0.810 |
Why?
|
| Noise, Occupational | 1 | 2022 | 3 | 0.770 |
Why?
|
| Child, Preschool | 7 | 2025 | 4046 | 0.750 |
Why?
|
| Occupational Exposure | 1 | 2022 | 111 | 0.690 |
Why?
|
| Child | 11 | 2025 | 7194 | 0.630 |
Why?
|
| Health Services Accessibility | 4 | 2025 | 444 | 0.600 |
Why?
|
| Referral and Consultation | 5 | 2023 | 288 | 0.580 |
Why?
|
| Community Health Services | 3 | 2019 | 102 | 0.570 |
Why?
|
| Ear Diseases | 2 | 2019 | 28 | 0.550 |
Why?
|
| Humans | 25 | 2025 | 52441 | 0.470 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2023 | 53 | 0.470 |
Why?
|
| Noise | 2 | 2022 | 42 | 0.460 |
Why?
|
| Hearing Aids | 4 | 2019 | 70 | 0.440 |
Why?
|
| Schools | 4 | 2023 | 175 | 0.420 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2025 | 625 | 0.400 |
Why?
|
| Prospective Studies | 2 | 2025 | 2433 | 0.310 |
Why?
|
| Round Window, Ear | 1 | 2018 | 7 | 0.300 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2018 | 4 | 0.300 |
Why?
|
| Hearing Loss, Sudden | 1 | 2018 | 3 | 0.300 |
Why?
|
| Tympanic Membrane | 1 | 2018 | 41 | 0.290 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 1 | 2017 | 5 | 0.270 |
Why?
|
| Acoustic Stimulation | 1 | 2017 | 93 | 0.270 |
Why?
|
| Audiometry | 3 | 2022 | 35 | 0.270 |
Why?
|
| Infant | 2 | 2025 | 3709 | 0.260 |
Why?
|
| Risk Factors | 2 | 2025 | 3971 | 0.260 |
Why?
|
| Students | 2 | 2019 | 230 | 0.250 |
Why?
|
| Dexamethasone | 1 | 2018 | 434 | 0.250 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 69 | 0.250 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 96 | 0.230 |
Why?
|
| Adolescent | 5 | 2023 | 6713 | 0.230 |
Why?
|
| Nutritional Status | 1 | 2025 | 146 | 0.220 |
Why?
|
| Prevalence | 3 | 2023 | 1016 | 0.220 |
Why?
|
| Environmental Exposure | 1 | 2025 | 225 | 0.210 |
Why?
|
| Breast Feeding | 1 | 2025 | 201 | 0.200 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2023 | 6 | 0.200 |
Why?
|
| Incidence | 1 | 2025 | 1096 | 0.190 |
Why?
|
| Mass Screening | 4 | 2019 | 354 | 0.180 |
Why?
|
| Male | 5 | 2025 | 26874 | 0.160 |
Why?
|
| Quality of Life | 3 | 2020 | 893 | 0.160 |
Why?
|
| Female | 5 | 2025 | 28277 | 0.160 |
Why?
|
| Preventive Medicine | 1 | 2018 | 22 | 0.140 |
Why?
|
| Research Design | 1 | 2020 | 368 | 0.140 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 13 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 871 | 0.130 |
Why?
|
| Acoustic Impedance Tests | 1 | 2023 | 8 | 0.100 |
Why?
|
| Ear, Middle | 1 | 2023 | 19 | 0.100 |
Why?
|
| Young Adult | 1 | 2022 | 4346 | 0.100 |
Why?
|
| Developing Countries | 2 | 2025 | 64 | 0.090 |
Why?
|
| Adult | 2 | 2022 | 14205 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2019 | 1349 | 0.080 |
Why?
|
| Instillation, Drug | 1 | 2018 | 2 | 0.080 |
Why?
|
| Sampling Studies | 1 | 2018 | 38 | 0.070 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 317 | 0.070 |
Why?
|
| Administration, Topical | 1 | 2018 | 62 | 0.070 |
Why?
|
| Community Health Workers | 1 | 2019 | 58 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 2 | 2019 | 112 | 0.070 |
Why?
|
| Government Regulation | 1 | 2018 | 14 | 0.070 |
Why?
|
| Program Development | 1 | 2019 | 164 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 89 | 0.070 |
Why?
|
| Hyperacusis | 1 | 2017 | 1 | 0.070 |
Why?
|
| Labyrinth Diseases | 1 | 2017 | 8 | 0.070 |
Why?
|
| Auditory Threshold | 1 | 2017 | 54 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 271 | 0.070 |
Why?
|
| Tinnitus | 1 | 2017 | 62 | 0.060 |
Why?
|
| Patient Safety | 1 | 2017 | 102 | 0.060 |
Why?
|
| Prosthesis Fitting | 1 | 2016 | 11 | 0.060 |
Why?
|
| Ear Neoplasms | 1 | 2016 | 10 | 0.060 |
Why?
|
| Intracranial Hemorrhages | 1 | 2016 | 43 | 0.060 |
Why?
|
| Middle Aged | 3 | 2018 | 13133 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 1223 | 0.060 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2016 | 69 | 0.060 |
Why?
|
| Otolaryngology | 1 | 2025 | 62 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2294 | 0.050 |
Why?
|
| Crowding | 1 | 2022 | 15 | 0.050 |
Why?
|
| Family Characteristics | 1 | 2022 | 59 | 0.050 |
Why?
|
| Water | 1 | 2022 | 87 | 0.050 |
Why?
|
| Comparative Effectiveness Research | 1 | 2021 | 51 | 0.050 |
Why?
|
| Stroke | 1 | 2016 | 527 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 3449 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2023 | 365 | 0.040 |
Why?
|
| Aged | 2 | 2018 | 10242 | 0.040 |
Why?
|
| Hearing | 1 | 2020 | 62 | 0.040 |
Why?
|
| Poverty | 1 | 2021 | 218 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2018 | 5508 | 0.040 |
Why?
|
| Developed Countries | 1 | 2018 | 17 | 0.030 |
Why?
|
| United States | 1 | 2018 | 5215 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2018 | 120 | 0.030 |
Why?
|
| Disabled Persons | 1 | 2018 | 72 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 1677 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 249 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2018 | 6694 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 930 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 938 | 0.030 |
Why?
|